Search

Search Constraints

You searched for: Author/Creator Bjaanæs, Maria Moksnes

Search Results

1. A trans‐omics assessment of gene–gene interaction in early‐stage NSCLC. Issue 1 (5th December 2022)

2. Atezolizumab and stereotactic body radiotherapy in patients with advanced non‐small cell lung cancer: safety, clinical activity and ctDNA responses—the ComIT‐1 trial. Issue 3 (22nd November 2022)

3. EGLN2 DNA methylation and expression interact with HIF1A to affect survival of early-stage NSCLC. Issue 2 (1st February 2019)

4. Epigenetic–smoking interaction reveals histologically heterogeneous effects of TRIM27 DNA methylation on overall survival among early‐stage NSCLC patients. Issue 11 (3rd September 2020)

5. Epigenome‐wide three‐way interaction study identifies a complex pattern between TRIM27, KIAA0226, and smoking associated with overall survival of early‐stage NSCLC. Issue 3 (7th January 2022)

6. Genome‐wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis. Issue 2 (6th November 2015)

7. Improved adaptive radiotherapy to adjust for anatomical alterations during curative treatment for locally advanced lung cancer. (April 2021)

8. SIPA1L3 methylation modifies the benefit of smoking cessation on lung adenocarcinoma survival: an epigenomic–smoking interaction analysis. Issue 5 (17th April 2019)

9. Unique microRNA‐profiles in EGFR‐mutated lung adenocarcinomas. Issue 8 (14th March 2014)